Stay updated on Biogen Press Releases

Sign up to get notified when there's something new on the Biogen Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Biogen Press Releases page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added two new news items about Biogen's conference participation (Leerink Global Healthcare Conference 2026 and TD Cowen 46th Annual Health Care Conference). Removed two older press releases (January 6, 2026 and January 5, 2026).
    Difference
    6%
    Check dated 2026-03-04T12:56:46.000Z thumbnail image
  2. Check
    18 days ago
    Change Detected
    Summary
    A new press release titled 'Biogen Announces Board Chair Transition' dated February 11, 2026 has been added to the News section.
    Difference
    0.7%
    Check dated 2026-02-18T06:53:33.000Z thumbnail image
  3. Check
    25 days ago
    Change Detected
    Summary
    Three new News releases were added: Nature Medicine publishes the DEVOTE nusinersen SMA results (Feb 4, 2026); Biogen Reports Fourth Quarter and Full Year 2025 Results (Feb 6, 2026); and LEQEMBI subcutaneous formulation designated for priority review in China (Feb 8, 2026).
    Difference
    2%
    Check dated 2026-02-11T06:40:32.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    A new Biogen news item appears on the page: 'Biogen’s Litifilimab Receives FDA Breakthrough Therapy Designation for Cutaneous Lupus Erythematosus, a Disease With No Targeted Treatment Options' dated January 28, 2026.
    Difference
    0.8%
    Check dated 2026-02-04T05:12:16.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    A new news release item was added to the News Releases page announcing FDA Accepts LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease under Priority Review (January 25, 2026).
    Difference
    0.8%
    Check dated 2026-01-28T03:32:21.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Added two Biogen News releases: the Q4 and full-year 2025 financial results announcement (February 6, 2026) and the European Commission approval of a high-dose Spinraza regimen for SMA (January 12, 2026).
    Difference
    2%
    Check dated 2026-01-14T01:44:19.000Z thumbnail image

Stay in the know with updates to Biogen Press Releases

Enter your email address, and we'll notify you when there's something new on the Biogen Press Releases page.